Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep 24;10(10):133.
doi: 10.3390/bios10100133.

Point of Care Diagnostics in Resource-Limited Settings: A Review of the Present and Future of PoC in Its Most Needed Environment

Affiliations
Review

Point of Care Diagnostics in Resource-Limited Settings: A Review of the Present and Future of PoC in Its Most Needed Environment

Benjamin Heidt et al. Biosensors (Basel). .

Abstract

Point of care (PoC) diagnostics are at the focus of government initiatives, NGOs and fundamental research alike. In high-income countries, the hope is to streamline the diagnostic procedure, minimize costs and make healthcare processes more efficient and faster, which, in some cases, can be more a matter of convenience than necessity. However, in resource-limited settings such as low-income countries, PoC-diagnostics might be the only viable route, when the next laboratory is hours away. Therefore, it is especially important to focus research into novel diagnostics for these countries in order to alleviate suffering due to infectious disease. In this review, the current research describing the use of PoC diagnostics in resource-limited settings and the potential bottlenecks along the value chain that prevent their widespread application is summarized. To this end, we will look at literature that investigates different parts of the value chain, such as fundamental research and market economics, as well as actual use at healthcare providers. We aim to create an integrated picture of potential PoC barriers, from the first start of research at universities to patient treatment in the field. Results from the literature will be discussed with the aim to bring all important steps and aspects together in order to illustrate how effectively PoC is being used in low-income countries. In addition, we discuss what is needed to improve the situation further, in order to use this technology to its fullest advantage and avoid "leaks in the pipeline", when a promising device fails to take the next step of the valorization pathway and is abandoned.

Keywords: bottlenecks to usage by patients; low-income countries; point of care diagnostics; resource-limited settings.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Migliozzi and Guibentif et al., looked at PoC bottlenecks from a technological standpoint. Figure re-used from [4] with permission under open-access creative commons copyright agreement.
Figure 2
Figure 2
Pai et al., investigated PoC use within different usage scenarios. Figure adapted from [5] with permission under open-access copyright agreement.
Figure 3
Figure 3
Segmentation of stages a PoC device has to pass to be able to bring a benefit to the patient.
Figure 4
Figure 4
Identified Problems along the value chain.
Figure 5
Figure 5
Identified Pivotal Points and Influencing Forces.

Similar articles

Cited by

References

    1. Boutayeb A. The impact of infectious diseases on the development of Africa. In: Preedy V.R., Watson R.R., editors. The Handbook of Disease Burdens and Quality of Life Measures. Springer; New York, NY, USA: 2010. pp. 1171–1188.
    1. Kuupiel D., Bawontuo V., Drain P.K., Gwala N., Mashamba-Thompson T.P. Supply chain management and accessibility to point-of-care testing in resource-limited settings: A systematic scoping review. BMC Heal. Serv. Res. 2019;19:519. doi: 10.1186/s12913-019-4351-3. - DOI - PMC - PubMed
    1. Starr A., Graef K.M., Dent J. Fostering innovative product development for neglected tropical diseases through partnerships. Pharm. Pat. Anal. 2016;5:391–400. doi: 10.4155/ppa-2016-0038. - DOI - PubMed
    1. Migliozzi D., Guibentif T. Assessing the potential deployment of biosensors for point-of-care diagnostics in developing countries: Technological, economic and regulatory aspects. Biosensors. 2018;8:119. doi: 10.3390/bios8040119. - DOI - PMC - PubMed
    1. Pai N.P., Vadnais C., Denkinger C., Engel N., Pai M. Point-of-care testing for infectious diseases: Diversity, complexity, and barriers in low-and middle-income countries. PLoS Med. 2012;9:e1001306. doi: 10.1371/journal.pmed.1001306. - DOI - PMC - PubMed

LinkOut - more resources